Most Active InvestorsFind investorsPricing
Start for free
Start for free
VMS Asset Management logo

VMS Asset Management

Asia, Hong Kong Island, Hong Kong, Hong Kong

Description

VMS Asset Management is a leading alternative asset management firm that provides private equity and structured finance services.

Investor Profile

VMS Asset Management has backed more than 18 startups, with 0 new investments in the last 12 months alone. The firm has led 4 rounds, about 22% of its total and boasts 16 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series C, Series A, Series B rounds (top funding stages).
  • Majority of deals are located in China, United States, United Kingdom.
  • Strong thematic focus on Biotechnology, Health Care, Biopharma.

Stage Focus

  • Series C (33%)
  • Series A (22%)
  • Series B (17%)
  • Post Ipo Equity (6%)
  • Series E (6%)
  • Series F (6%)
  • Series G (6%)
  • Series D (6%)

Country Focus

  • China (56%)
  • United States (28%)
  • United Kingdom (6%)
  • Taiwan (6%)
  • Israel (6%)

Industry Focus

  • Biotechnology
  • Health Care
  • Biopharma
  • Medical
  • Big Data
  • E-commerce
  • Blockchain
  • Cryptocurrency
  • Information Technology
  • Saas
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does VMS Asset Management frequently co-invest with?

Sequoia Capital
Sequoia Capital
North America, California, United States, Menlo Park
Co-Investments: 2
IDG Capital
IDG Capital
Asia, Beijing, China, Beijing
Co-Investments: 2
Legend Capital
Legend Capital
Asia, Beijing, China, Beijing
Co-Investments: 3
DCM Ventures
DCM Ventures
North America, California, United States, Menlo Park
Co-Investments: 2
Comcast Ventures
Comcast Ventures
North America, California, United States, San Francisco
Co-Investments: 2
5Y Capital
5Y Capital
Asia, Shanghai, China, Xuhui
Co-Investments: 3
AP
AM Partners
North America, Hawaii, United States, Honolulu
Co-Investments: 1
HongShan
HongShan
Asia, Beijing, China, Beijing
Co-Investments: 3
Qiming Venture Partners
Qiming Venture Partners
Asia, Shanghai, China, Shanghai
Co-Investments: 2
Panacea Venture
Panacea Venture
North America, Midland, Cayman Islands, Grand Cayman
Co-Investments: 2

Which angels does VMS Asset Management often collaborate with?

TF
Tony Fadell
Europe, Ile-de-France, France, Paris
Shared Deals: 1
PG
Peter Guber
North America, California, United States, Los Angeles
Shared Deals: 1

What are some of recent deals done by VMS Asset Management?

Hope Medicine

Nanjing, Jiangsu, China

Hope Medicine is a science-driven clinical stage biopharmaceutical company

Health CareMedical
Series BFeb 7, 2024
Amount Raised: $28,117,531
Laiye

Beijing, Beijing, China

Laiye is an interactive platform that offers consumers and enterprises with intelligent assistant products.

AppsArtificial Intelligence (AI)EnterpriseInternetMobileMobile AppsMobile PaymentsNatural Language ProcessingRobotic Process Automation (RPA)
Series CApr 18, 2022
Amount Raised: $70,000,000
Slope Finance

New York, New York, United States

Slope Finance is a community-based decentralized exchange built on Solana.

BlockchainCryptocurrencyNon-Fungible Token (NFT)
Series AFeb 24, 2022
Amount Raised: $8,000,000
HAI ROBOTICS

Shenzhen, Guangdong, China

HAI ROBOTICS creates and delivers value to every warehouse and factory with advanced robotics and AI algorithm.

Industrial AutomationLogisticsRoboticsSupply Chain ManagementWarehouse AutomationWarehousing
Series CSep 21, 2021
Amount Raised: $30,000,000
Inmagene Biopharmaceuticals

San Diego, California, United States

Inmagene is a clinical-stage biotech company developing innovative and differentiated therapies for immunological and inflammatory diseases.

BiopharmaBiotechnologyHealth Care
Series CJun 1, 2021
Amount Raised: $100,000,000
BlissBio

Hangzhou, Zhejiang, China

Bliss Bio is a biopharmaceutical company focused on development of tumor targeting and immunotherapy drugs.

BiopharmaBiotechnologyPharmaceutical
Series BApr 16, 2021
Amount Raised: $61,341,226
Chime Biologics

Wuhan, Hubei, China

Chime Biologics is a biopharmaceutical development and manufacturing company.

BiometricsBiopharmaBiotechnologyHealth CareManufacturing
Series AMar 25, 2021
Amount Raised: $190,000,000
New Horizon Health

Hangzhou, Zhejiang, China

New Horizon Health is a bio-tech company focusing on early screening and genetic testing services for high-incidence cancer homes.

Big DataBiotechnologyHealth CareMedical
Series CMay 24, 2019
Amount Raised: $66,500,000
Eden Biologics

Hsinchu, T'ai-wan, Taiwan

Eden Biologics is a biopharmaceutical company that develops biosimilars and accelerates the development programs for clients & partners.

BiopharmaBiotechnologyHealth CareHealth DiagnosticsMedicalPharmaceutical
Post Ipo EquityMay 29, 2018
Amount Raised: $106,000,000
Pony.ai

Fremont, California, United States

Pony.ai develops autonomous vehicle technology using artificial intelligence.

Artificial Intelligence (AI)AutomotiveAutonomous VehiclesTransportation
Series AJan 15, 2018
Amount Raised: $112,000,000
c-shape-1
c-shape-2

Ready to Raise Capital?

Founders in our network have raised from Y Combinator, Sequoia, a16z, and more. You could be next.

Find investors

Pages

Most Active Investors Find InvestorsNewsletterPricing

Free tools

Pre-Money and Post-Money Valuation Calculator